The Current Ratio as of December 2024 (TTM) for Evoke Pharma, Inc. (EVOK) is 1.44

According to Evoke Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.44. This represents a change of -9.57% compared to the average of 1.59 of the last 4 quarters.

Evoke Pharma, Inc. (EVOK) Historical Current Ratio (quarterly & annually)

How has EVOK Current Ratio performed in the past?

The mean historical Current Ratio of Evoke Pharma, Inc. over the last ten years is 4.84. The current 1.44 Current Ratio has changed 2.87% with respect to the historical average. Over the past ten years (40 quarters), EVOK's Current Ratio was at its highest in in the March 2017 quarter at 13.05. The Current Ratio was at its lowest in in the June 2016 quarter at 0.75.

Evoke Pharma, Inc. (EVOK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Evoke Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evoke Pharma, Inc. (EVOK) Average Current Ratio

How has EVOK Current Ratio performed in the past?

The current Current Ratio of Evoke Pharma, Inc. (EVOK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Evoke Pharma, Inc. (EVOK) Current Ratio vs. Peers

How is EVOK’s Current Ratio compared to its peers?

Evoke Pharma, Inc.’s Current Ratio is greater than Petros Pharmaceuticals, Inc. (0.85), greater than Cumberland Pharmaceuticals Inc. (1.13), greater than Agile Therapeutics, Inc. (0.55), greater than PainReform Ltd. (0.61), less than Aquestive Therapeutics, Inc. (6.37), greater than Adamis Pharmaceuticals Corporation (0.58), less than Guardion Health Sciences, Inc. (16.67), less than AcelRx Pharmaceuticals, Inc. (4.42), less than Eagle Pharmaceuticals, Inc. (1.70), less than Regencell Bioscience Holdings Limited (41.92), less than Procaps Group S.A. (1.47), less than Incannex Healthcare Limited (2.88), greater than Journey Medical Corporation (1.38), less than Jupiter Wellness, Inc. (1.90), less than Avadel Pharmaceuticals plc (2.97), less than Biofrontera Inc. (1.53), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), greater than Akanda Corp. (1.41), greater than China Pharma Holdings, Inc. (0.79),

Build a custom stock screener for Evoke Pharma, Inc. (EVOK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evoke Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evoke Pharma, Inc. (EVOK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evoke Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.